Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
04/2010
04/14/2010EP1786439B1 Methods of activating nkt cells
04/14/2010EP1576089B1 Expansion of renewable stem cell populations
04/14/2010EP1513397B1 Transgenic ungulates capable of human antibody production
04/14/2010EP1440085B1 Transient immortalization of cells by oncogenic proteins or telomerase
04/14/2010EP1406928B1 Ntb-a, a surface molecule involved in natural killer cells activity
04/14/2010EP1399483B1 Antibodies to insulin-like growth factor i receptor
04/14/2010EP1364197B1 ATP-based assay for the determination of the proliferation status of hematopoietic stem and progenitor cells
04/14/2010EP1322749B1 Assay for rapid detection of human activated protein c and highly specific monoclonal antibody therefor
04/14/2010EP1305418B1 Human monoclonal antibody against hepatitis c virus e2 glycoprotein
04/14/2010EP1294922B1 Treating cancer using organelle crystallizing agents
04/14/2010EP1294866B1 Use of acrp30 globular head to promote increases in muscle mass and muscle differentiation
04/14/2010EP1255437B1 Transgenic animal expressing a multiple mutated form of presenilin 1
04/14/2010EP1221969B1 Activation of antigen-specific t cells by virus/antigen-treated dendritic cells
04/14/2010EP0961833B1 Human plasma hyaluronidase
04/14/2010EP0831903B1 Connective tissue growth factor
04/14/2010CN1943560B Sandwich structure magnetic composite micro ball with functional shell layer and its preparing method
04/14/2010CN101693896A 醛脱氢酶基因 Aldehyde dehydrogenase gene
04/14/2010CN101693894A Avian influenza virus H5N1 pseudotype virus, process for preparation and special DNA fragment thereof
04/14/2010CN101693889A Design of beta-sheet proteins with specific binding properties
04/14/2010CN101693885A Anti-HBV (hepatitis B Virus) nicotine medicine composition
04/14/2010CN101693884A Method for separating and extracting stem cells from placenta, umbilical cord or adipose tissue
04/14/2010CN101693742A anti-igf-i receptor antibody
04/14/2010CN101693739A Chlorogenic acid synthesis associated protein and encoding gene thereof and application
04/14/2010CN101693736A Novel peptides
04/14/2010CN101194595B Regeneration method for lateral bud evoked callus and plant strain of eremochloa ophiuroides
04/14/2010CN101138319B Tristellateia australasiae tissue culturing and propagating method
04/14/2010CN101019503B Germ plasm preserving method for kelp
04/13/2010US7696408 Method to enhance Agrobacterium-mediated transformation of plants
04/13/2010US7696405 Zea mays provides a high level of specificity for expression in developing pollen; plants comprising suppressed male fertility genes, useful as females in hybrid plant production; useful for generating fertile parental plants that, when crossed generate sterile progeny plants
04/13/2010US7696404 Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions
04/13/2010US7696403 Drug screening for an allergosis; screening an inducer/promoter or an inhibitor for Th2-mediated immune response or a promoter or an inhibitor for PIR-A function
04/13/2010US7696336 Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer
04/13/2010US7696333 increased yield in the production of L-lactic acid
04/13/2010US7696332 Replication vector showing cell-specific expression
04/13/2010US7696324 Humanized antibodies
04/13/2010US7696321 Molecules and methods for inhibiting shedding of KIM-1
04/13/2010US7696319 PRO1772 antibodies
04/13/2010US7696317 Mammalian genes; related reagents and methods
04/13/2010US7696316 21910, 56634, 55053, 2504, 15977, 14760, 25501, 17903, 3700, 21529, 26176, 26343, 56638, 18610, 33217, 21967, H1983, M1983, 38555 or 593 molecules and uses therefor
04/13/2010US7696314 Hypoallergenic mutant polypeptides based on fish parvalbumin
04/13/2010US7696308 Fabricated in baculovirus; for penetration into human erythrocytes in event of infection; vaccines against malaria
04/13/2010US7696172 culture product produced by culturing a recombinant host cell under suitable conditions to express the polypeptide; has an oncogenic activity; treating liver disorder cirrhosis, or pancreas disorder
04/13/2010US7696157 Plurality of isolated erythropoietin-like molecules; reperfusion injuries; antiischemic, antihypoxic, antiinflammatory gents; neurodegenerative or nervous system disorders; genetic engineering and expression
04/13/2010US7696151 Providing a screening assay having stearoyl-CoA desaturase biological activity, contacting sceening assay with a test compound and measuring the biological activity
04/13/2010US7695967 membrane comprises appropriate microtopography and surface chemical modifications to facilitate the production of adherent and oriented cells that phenotypically resemble cells in vivo; uses biocompatible, deformable membrane for the growth of cells e.g., muscle cells
04/13/2010US7695966 Method for the separation and sorting of different biological objects utilizing differences in their viscoelastic properties
04/13/2010US7695965 Exposing embryonic stem cells culture to cells expressing activin receptor-like kinase (ALK) receptor, transplanting tissues into mammal, recovering insulin secreting cells; endocrine cell therapy
04/13/2010US7695964 Compositions and methods for generating short double-stranded RNA using mutated RNAse III
04/13/2010US7695963 Methods for increasing definitive endoderm production
04/13/2010US7695962 Polypeptides and nucleic acids encoding same
04/13/2010US7695961 Insulin related transcription factor and uses thereof
04/13/2010US7695958 implantable or circulation type hybrid artificial organ, material production devices (e.g. bioreactors), and cell incubators
04/13/2010US7695957 method for increasing cell culture by means of the bioreactor and the intracellular or extracellular production of metabolites; shear stress to which the cell cultures are subjected is sufficiently reduced so as to allow cell vitality even at the high densities
04/13/2010US7695940 Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics
04/13/2010US7695939 Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions
04/13/2010US7695938 Vectors and recombinant host cells comprising nucleic acid molecules encoding Fibroblast Growth Factor-like polypeptides
04/13/2010US7695936 Knobs and holes heteromeric polypeptides
04/13/2010US7695902 Contacting test solution containing Rna and enzyme; hybridization
04/13/2010US7695899 Using genotoxically stressed checkpoint tissues as tools in detecting and monitoring efficacy of antitumor agents; drug screening
04/13/2010US7695723 Methods of treating neurological conditions with hematopoietic growth factors
04/13/2010US7695720 target VEGFR2 (KDR/flk-1); for treating and preventing tumors
04/13/2010US7695715 Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases
04/13/2010US7695713 Isolation and identification of T cells
04/13/2010US7695712 Recovery of tissue function following administration of B cells to injured tissue
04/13/2010US7695627 Tangential flow filtration devices and methods for leukocyte enrichment
04/13/2010US7695426 Methods for enhancing viability
04/13/2010CA2472280C Cytotoxic cyplasin of the sea hare, aplysia punctata, cdna cloning and expression of bioreactive recombinants
04/13/2010CA2449747C Use of fkbp chaperones as expression tool
04/13/2010CA2418848C Cng2b: a novel human cyclic nucleotide-gated ion channel
04/13/2010CA2395781C Detection and treatment of polycystic kidney disease
04/13/2010CA2372468C Compounds exhibiting an antibiotic activity
04/13/2010CA2350080C Novel serine protease bssp2
04/13/2010CA2348773C Functional antagonists of hedgehog activity
04/13/2010CA2330206C Poly(adp-ribose) polymerase gene
04/13/2010CA2321992C Banana streak virus promoter and detection
04/13/2010CA2257357C Humanized antibodies with modified glycosylation
04/13/2010CA2203528C Methods and kits using macrophage stimulating protein
04/13/2010CA2200868C Cdr-grafted type iii anti-cea humanized mouse monoclonal antibodies
04/13/2010CA2189015C Methods and compositions for the treatment of glomerulonephritis and other inflammatory diseases
04/13/2010CA2165098C Genomic dna fragments containing regulatory and coding sequences for the .beta.2-subunit of the neuronal nicotinic acetylcholine receptor and transgenic animals made using these fragments or mutated fragments
04/13/2010CA2144056C Cd27 ligand
04/11/2010WO2010126137A1 Anti-cadherin antibody
04/08/2010WO2010039933A2 Methods and compositions for high-resolution micropatterning for cell culture
04/08/2010WO2010039781A1 Method for dedifferentiating melanocytes
04/08/2010WO2010039681A1 Compositions and methods for the treatment of vitiligo
04/08/2010WO2010039679A1 Compositions for proliferation of cells and related methods
04/08/2010WO2010039649A2 Flavivirus-based system for production of hepatitis c virus (hcv)
04/08/2010WO2010039615A2 Papio cynocephalus toll-like receptor 3
04/08/2010WO2010039613A2 A lolium multiflorum line inducing genome loss
04/08/2010WO2010039241A1 Methods for isolating very small embryonic-like (vsel) stem cells
04/08/2010WO2010038904A1 Induced pluripotent stem cell free of exogenous nuclear reprogramming factor or dna encoding the factor and method for producing the cell
04/08/2010WO2010038153A1 Use of sox transcription factor acti\ators for stimulating chondrogenesis
04/08/2010WO2010037884A1 In vitro cellular composition with simultaneous overexpression of mutated human genes ps1m146v, appswe and taup301l
04/08/2010WO2010037826A2 Method of enriching stem cells in culture
04/08/2010WO2010037784A1 G6pc2-encoded beta cell surface tags
04/08/2010WO2010037208A1 Production of products of pharmaceutical interest in plant cell cultures
04/08/2010WO2010011644A3 Differentiated anucleated cells and method for preparing the same
04/08/2010WO2010008486A3 Pluripotent cell lines and methods of use thereof
04/08/2010WO2009137829A3 Directed stem cell recruitment
04/08/2010WO2009071334A3 Transposon-mediated mutagenesis in spermatogonial stem cells